Physician profile
Christopher Trotter
NPI 1538321393
$2,958.51
in general payments reported to CMS, 2019-2025
16 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.41 · 2020: $19.90 · 2022: $56.66 · 2023: $2,375 · 2024: $271 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,871 · Travel and Lodging: $948.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,871.28 |
| Travel and Lodging | $948.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,744.03 | 2022-2023 | Optis |
| Boston Scientific Corporation | $433.76 | 2023-2025 | Watchman Flx, Avvigo Guidance System, Rotapro |
| Edwards Lifesciences Corporation | $208.04 | 2023-2025 | Sapien 3 Ultra Resilia |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $173.22 | 2019-2025 | Lifevest |
| Abiomed | $59.47 | 2023-2025 | Impella |
| Penumbra, INC. | $56.10 | 2023 | Indigo System |
| Cordis US Corp. | $43.47 | 2023 | Mynx Control |
| Acist Medical Systems, INC. | $41.53 | 2023 | |
| Janssen Pharmaceuticals, INC | $39.73 | 2019 | |
| Medtronic, INC. | $35.25 | 2022 | |
| Cardiva Medical, INC. | $35.15 | 2023 | Cardiva Vascade 6/7f Vcs |
| Shockwave Medical, INC | $21.93 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Ge Healthcare | $19.90 | 2020 | |
| Irhythm Technologies, INC. | $18.98 | 2024 | Zio Xt Patch, Zio Monitor |
| Amgen INC. | $16.57 | 2025 | Repatha |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $11.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Trotter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.